JP2024533314A5 - - Google Patents

Info

Publication number
JP2024533314A5
JP2024533314A5 JP2024515070A JP2024515070A JP2024533314A5 JP 2024533314 A5 JP2024533314 A5 JP 2024533314A5 JP 2024515070 A JP2024515070 A JP 2024515070A JP 2024515070 A JP2024515070 A JP 2024515070A JP 2024533314 A5 JP2024533314 A5 JP 2024533314A5
Authority
JP
Japan
Prior art keywords
nucleic acid
target nucleic
polypeptide
sequence
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024515070A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024533314A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/076064 external-priority patent/WO2023039441A1/en
Publication of JP2024533314A publication Critical patent/JP2024533314A/ja
Publication of JP2024533314A5 publication Critical patent/JP2024533314A5/ja
Pending legal-status Critical Current

Links

JP2024515070A 2021-09-08 2022-09-07 遺伝子編集システム成分のtransでの動員 Pending JP2024533314A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163242003P 2021-09-08 2021-09-08
US63/242,003 2021-09-08
PCT/US2022/076064 WO2023039441A1 (en) 2021-09-08 2022-09-07 Recruitment in trans of gene editing system components

Publications (2)

Publication Number Publication Date
JP2024533314A JP2024533314A (ja) 2024-09-12
JP2024533314A5 true JP2024533314A5 (https=) 2025-09-16

Family

ID=85506906

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024515070A Pending JP2024533314A (ja) 2021-09-08 2022-09-07 遺伝子編集システム成分のtransでの動員

Country Status (10)

Country Link
US (1) US20250305002A1 (https=)
EP (1) EP4399308A4 (https=)
JP (1) JP2024533314A (https=)
KR (1) KR20240099167A (https=)
CN (1) CN118318041A (https=)
AU (1) AU2022343271A1 (https=)
CA (1) CA3231678A1 (https=)
IL (1) IL311223A (https=)
MX (1) MX2024002928A (https=)
WO (1) WO2023039441A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024197103A2 (en) * 2023-03-21 2024-09-26 Tessera Therapeutics, Inc. Modified template guide rna molecules
WO2026015832A2 (en) * 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Reverse transcriptases and gene editing systems comprising such

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7658579B2 (ja) * 2018-10-19 2025-04-08 ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム 操作された長鎖散在反復エレメント(line)トランスポゾンおよびそれらの使用方法
WO2020148206A1 (en) * 2019-01-14 2020-07-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and kits for generating and selecting a variant of a binding protein with increased binding affinity and/or specificity
WO2020191233A1 (en) * 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
CN115023499A (zh) * 2019-08-16 2022-09-06 麻省理工学院 使用CRISPR/Cas13的靶向反式剪接
US12435330B2 (en) * 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
US12173335B2 (en) * 2020-01-06 2024-12-24 Pairwise Plants Services, Inc. Recruitment of DNA polymerase for templated editing

Similar Documents

Publication Publication Date Title
Brown et al. Specificities of protein-protein and protein-DNA interaction of GABP alpha and two newly defined ets-related proteins.
Wu et al. Structural and functional interaction between the human DNA repair proteins DNA ligase IV and XRCC4
Tarver et al. Enteric β-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection
Akashi et al. Number and location of AUUUA motifs: role in regulating transiently expressed RNAs
Slany et al. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX
JP2023517294A5 (https=)
CA3202977A1 (en) Compositions and methods for epigenetic editing
JP2024533311A5 (https=)
JP2017018125A5 (https=)
JP2017537611A5 (https=)
JP2021513863A5 (https=)
JP2024520528A5 (https=)
JP2024533316A5 (https=)
JP2024533314A5 (https=)
JPS59501096A (ja) 構造遺伝子の製造および発現
JP2006518204A (ja) トランスポゾンに基づく標的化システム
EA005581B1 (ru) ПОЛИПЕПТИДЫ ЦИТОКИНА Zcyto10 ЧЕЛОВЕКА И МЫШИ, КОДИРУЮЩИЕ ИХ ПОЛИНУКЛЕОТИДЫ И АНТИТЕЛА К УКАЗАННЫМ ПОЛИПЕПТИДАМ
JP2022520285A5 (https=)
JP2023554504A5 (https=)
JP2024511131A5 (https=)
WO1997021809A1 (en) Dna sequence encoding the tumor suppressor ing1
JPH05507203A (ja) 真核性発現ベクター系
Lopingco et al. Molecular Analysis of E vi 1, a Zinc Finger Oncogene Involved in Myeloid Leukemia
CN108329387B (zh) 癌症相关的肿瘤特异转录本lin28b-tst及其用途
JP2024507451A5 (https=)